Beijing Science Sun Pharmaceutical Co Ltd (300485) — Capital Reinvestment Ratio
Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Capital Reinvestment Ratio of 0.54x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥28.68 Million) in capital expenditures (CN¥15.52 Million). See 300485 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Beijing Science Sun Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Beijing Science Sun Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Beijing Science Sun Pharmaceutical Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see 300485 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.74x | CN¥135.97 Million | CN¥101.13 Million | ▼ -70.2% |
| 2023 | 2.49x | CN¥21.21 Million | CN¥52.91 Million | ▲ +536.5% |
| 2022 | 0.39x | CN¥110.43 Million | CN¥43.28 Million | ▲ +56.5% |
| 2021 | 0.25x | CN¥183.30 Million | CN¥45.91 Million | ▼ -43.9% |
| 2020 | 0.45x | CN¥263.73 Million | CN¥117.84 Million | ▼ -30.8% |
| 2019 | 0.65x | CN¥172.52 Million | CN¥111.42 Million | ▼ -52.2% |
| 2018 | 1.35x | CN¥146.52 Million | CN¥198.00 Million | ▲ +3.5% |
| 2017 | 1.31x | CN¥108.21 Million | CN¥141.25 Million | ▲ +89.0% |
| 2016 | 0.69x | CN¥212.89 Million | CN¥147.00 Million | ▲ +269.4% |
| 2015 | 0.19x | CN¥169.36 Million | CN¥31.65 Million | ▲ +342.6% |
| 2014 | 0.04x | CN¥214.23 Million | CN¥9.05 Million | ▼ -57.2% |
| 2013 | 0.10x | CN¥196.82 Million | CN¥19.42 Million | ▼ -81.4% |
| 2012 | 0.53x | CN¥151.93 Million | CN¥80.76 Million | ▲ +50.1% |
| 2011 | 0.35x | CN¥77.06 Million | CN¥27.29 Million | — |